Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma

被引:386
作者
Simon, MP
Pedeutour, F
Sirvent, N
Grosgeorge, J
Minoletti, F
Coindre, JM
TerrierLacombe, MJ
Mandahl, N
Craver, RD
Blin, N
Sozzi, G
TurcCarel, C
OBrien, KP
Kedra, D
Fransson, I
Guilbaud, C
Dumanski, JP
机构
[1] FAC MED NICE,CNRS URA 1462,LAB GENET CHROMOSOM TUMEURS,F-06107 NICE 02,FRANCE
[2] IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,I-20133 MILAN,ITALY
[3] INST BERGONIE,ANAT PATHOL LAB,F-33076 BORDEAUX,FRANCE
[4] INST GUSTAVE ROUSSY,LAB HISTOPATHOL A,F-94905 VILLEJUIF,FRANCE
[5] UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN
[6] NEW ORLEANS CHILDRENS HOSP,DEPT PATHOL,NEW ORLEANS,LA 70118
[7] UNIV TUBINGEN,ABT MOL GENET,D-72074 TUBINGEN,GERMANY
[8] KAROLINSKA HOSP,CLIN GENET UNIT,DEPT MOL MED,S-17176 STOCKHOLM,SWEDEN
关键词
D O I
10.1038/ng0197-95
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Dermatofibrosarcoma protuberans (DP), an infiltrative skin tumour of intermediate malignancy(1). presents specific features such as reciprocal translocations t(17;22)(q22;q13) and supernumerary ring chromosomes derived from the t(17;22)(2,3). In this report, the breakpoints from translocations and rings in DP and its juvenile form. giant cell fibroblastoma (GCF)(4.5), were characterised on the genomic and RNA level. These rearrangements fuse the platelet-derived growth factor B-chain (PDGFB, c-sis proto-oncogene) and the collagen type I alpha 1 (COL1A1) genes. PDGFB has transforming activity and is a potent mitogen for a number of cell types. but its role in oncogenic processes is not fully understood(6,7). COL1A1 is a major constituent of the connective tissue matrix(8). Neither PDGFB nor COL1A1 have so far been implicated in any tumour translocations. These gene fusions delete exon 1 of PDGFB, and release this growth factor from its normal regulation.
引用
收藏
页码:95 / 98
页数:4
相关论文
共 31 条
[11]   Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11 [J].
Kedra, D ;
Peyrard, M ;
Fransson, I ;
Collins, JE ;
Dunham, I ;
Roe, BA ;
Dumanski, JP .
HUMAN MOLECULAR GENETICS, 1996, 5 (05) :625-631
[12]   DERMATOFIBROSARCOMA PROTUBERANS - INCREASED GROWTH-RESPONSE TO PLATELET-DERIVED GROWTH FACTOR-BB IN CELL-CULTURE [J].
KIKUCHI, K ;
SOMA, Y ;
FUJIMOTO, M ;
KADONO, T ;
SATO, S ;
ABE, M ;
OHHARA, K ;
TAKEHARA, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 196 (01) :409-415
[13]   INVOLVEMENT OF CHROMOSOME-17 AND CHROMOSOME-22 IN DERMATOFIBROSARCOMA PROTUBERANS [J].
MINOLETTI, F ;
MIOZZO, M ;
PEDEUTOUR, F ;
SARD, L ;
PILOTTI, S ;
AZZARELLI, A ;
TURCCAREL, C ;
PIEROTTI, MA ;
SOZZI, G .
GENES CHROMOSOMES & CANCER, 1995, 13 (01) :62-65
[14]  
PDEUTOUR F, 1996, CELL GENET, V72, P171
[15]  
PEDEUTOUR F, 1995, CANCER RES, V55, P2400
[16]   CHROMOSOMAL TRANSLOCATIONS IN HUMAN CANCER [J].
RABBITTS, TH .
NATURE, 1994, 372 (6502) :143-149
[17]   THE 5' UNTRANSLATED SEQUENCE OF THE C-SIS/PLATELET-DERIVED GROWTH FACTOR-II TRANSCRIPT IS A POTENT TRANSLATIONAL INHIBITOR [J].
RAO, CD ;
PECH, M ;
ROBBINS, KC ;
AARONSON, SA .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (01) :284-292
[18]   NUCLEOTIDE-SEQUENCE OF TRANSFORMING HUMAN C-SIS CDNA CLONES WITH HOMOLOGY TO PLATELET-DERIVED GROWTH-FACTOR [J].
RATNER, L ;
JOSEPHS, SF ;
JARRETT, R ;
REITZ, MS ;
WONGSTAAL, F .
NUCLEIC ACIDS RESEARCH, 1985, 13 (14) :5007-5018
[19]   EXPANDED RANGE OF 11Q13 BREAKPOINTS WITH DIFFERING PATTERNS OF CYCLIN-D1 EXPRESSION IN B-CELL MALIGNANCIES [J].
RAYNAUD, SD ;
BEKRI, S ;
LEROUX, D ;
GROSGEORGE, J ;
KLEIN, B ;
BASTARD, C ;
GAUDRAY, P ;
SIMON, MP .
GENES CHROMOSOMES & CANCER, 1993, 8 (02) :80-87
[20]   THE BIOLOGY OF PLATELET-DERIVED GROWTH-FACTOR [J].
ROSS, R ;
RAINES, EW ;
BOWENPOPE, DF .
CELL, 1986, 46 (02) :155-169